Chinese cancer drug maker’s Hong Kong IPO gets red-hot response

Most visited

1 year ago full article

share

Kintor Pharmaceutical sees its HK$1.86 billion (US$240 million) IPO more than 500 times oversubscribed as investors keep betting on biotech start-ups to hit the jackpot with high-demand medicines. ...Read More

150o

65%
Menu

Leave a Comment